SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-122376
Filing Date
2019-04-26
Accepted
2019-04-26 16:15:56
Documents
4
Period of Report
2019-06-20
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d693631ddef14a.htm DEF 14A 291848
2 GRAPHIC g693631dsp002.jpg GRAPHIC 197165
3 GRAPHIC g693631dsp003.jpg GRAPHIC 121328
4 GRAPHIC g693631g02n60.jpg GRAPHIC 40361
  Complete submission text file 0001193125-19-122376.txt   787308
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37783 | Film No.: 19771951
SIC: 2834 Pharmaceutical Preparations